M&T Bank’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$487K Buy
24,180
+318
+1% +$5.73K ﹤0.01% 1206
2026
Q2
$413K Buy
23,862
+606
+3% +$8.3K ﹤0.01% 1298
2026
Q1
$289K Sell
23,256
-271
-1% -$3.64K ﹤0.01% 1398
2025
Q4
$296K Buy
+23,527
New +$269K ﹤0.01% 1407

Other funds holding AMRX

M&T Bank's AMRX Position: Q3 2026 in Review

M&T Bank increased its Amneal Pharmaceuticals (AMRX) stake by 1.3% in Q3 2026, buying an estimated $5.73K and bringing the position to 24,180 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #1206.

M&T Bank first reported a position in AMRX in Q4 2025 and has held it in 4 quarters since. 332 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • M&T Bank held 24,180 shares of Amneal Pharmaceuticals worth $487K as of Q3 2026.
  • M&T Bank bought 318 Amneal Pharmaceuticals shares in Q3 2026, an estimated $5.73K.
  • Amneal Pharmaceuticals made up ﹤0.01% of M&T Bank's portfolio in Q3 2026, its #1206 holding.
  • M&T Bank first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • 332 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on M&T Bank's 13F filing for Q3 2026, filed 10 Nov 2026.